Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Very Strong
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Telephone
61.3.8681.4050
Address
Unit 2 320 Lorimer Street Port Melbourne, Victoria (VIC) 3207
Description
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.1 - 2.78
Trade Value (12mth)
AU$718,913.00
1 week
-1.71%
1 month
-0.43%
YTD
36.5%
1 year
73.58%
All time high
4.08
EPS 3 yr Growth
-208.60%
EBITDA Margin
3.80%
Operating Cashflow
$5m
Free Cash Flow Return
6.20%
ROIC
6.40%
Interest Coverage
5.40
Quick Ratio
3.00
Shares on Issue (Fully Dilluted)
702m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
2.50
Date | Announcements |
---|---|
04 September 24 |
Pivotal Trial Recruitment Complete
×
Pivotal Trial Recruitment Complete |
02 September 24 |
Date of Annual General Meeting
×
Date of Annual General Meeting |
27 August 24 |
Webcast Recording for FY24 Results Presentation
×
Webcast Recording for FY24 Results Presentation |
23 August 24 |
Appendix 4E and FY24 Financial Statements
×
Appendix 4E and FY24 Financial Statements |
23 August 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
23 August 24 |
Notification regarding unquoted securities - PNV
×
Notification regarding unquoted securities - PNV |
23 August 24 |
Application for quotation of securities - PNV
×
Application for quotation of securities - PNV |
23 August 24 |
FY24 Results Presentation
×
FY24 Results Presentation |
16 August 24 |
FY24 Results Presentation
×
FY24 Results Presentation |
13 August 24 |
Canaccord Genuity Growth Conference Presentation
×
Canaccord Genuity Growth Conference Presentation |
23 July 24 |
FY24 Trading Result (unaudited)
×
FY24 Trading Result (unaudited) |
24 June 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
08 May 24 |
First $A9M sales month and $A10M revenue month
×
First $A9M sales month and $A10M revenue month |
08 May 24 |
Macquarie Australia Conference - Presentation
×
Macquarie Australia Conference - Presentation |
06 May 24 |
Appointment of General Counsel & Company Secretary
×
Appointment of General Counsel & Company Secretary |
26 April 24 |
Victorian Government Grant for Expansion of R&D Facility
×
Victorian Government Grant for Expansion of R&D Facility |
10 April 24 |
Notification regarding unquoted securities - PNV
×
Notification regarding unquoted securities - PNV |
04 March 24 |
India update
×
India update |
28 February 24 |
Webcast Recording - 1H24 Results
×
Webcast Recording - 1H24 Results |
27 February 24 |
Appendix 4D & 1H FY24 Report
×
Appendix 4D & 1H FY24 Report |
27 February 24 |
1H FY24 Results Presentation
×
1H FY24 Results Presentation |
16 February 24 |
Largest ever single order
×
Largest ever single order |
15 February 24 |
Webcast Details - 1H24 Results
×
Webcast Details - 1H24 Results |
22 January 24 |
1H24 Trading Result (unaudited)
×
1H24 Trading Result (unaudited) |
10 January 24 |
PolyNovo presents at Annual J.P. Morgan Heathcare Conference
×
PolyNovo presents at Annual J.P. Morgan Heathcare Conference |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.